Dr Ada Cuevas
Disclosure details
Advisor or Speaker: Abbott, Boerhinger Ingelheim, Teva, Pasteur, Tecnofarma, Saval, Novo-Nordisk, Galenicum, Axon Pharma, Merck.Advanced Center for Metabolic Medicine and Nutrition (CAMMYN) Santiago and Cleversalud Clinic, Rancagua, Chile
Dr Ada Cuevas attended medical school at the Faculty of Medicine of the Catholic University of Chile. Subsequently, she obtained a master’s in clinical nutrition from the Institute of Nutrition and Food Technology at the University of Chile.
Dr Cuevas obtained the Friends of the Center for Human Nutrition scholarship to pursue her postgraduate studies in Nutrition and Metabolism at the Center for Human Nutrition at the University of Texas, Southwestern Medical Center, Dallas USA.
In 2012, she received recognition from the World Obesity Federation (WOF) as an International Fellowship, and at present she is a Board member and Chair of the International Executive Committee of the Specialist Certification of Obesity Professional Education (SCOPE) of the WOF.
Between 2009 and 2015, she served as Director of the Committee for America of the International Atherosclerosis Society (IAS), currently working as a Senior Advisory Board member for this Society. She also founded the Chilean Atherosclerosis Working Group, a Chilean affiliate of the IAS. In 2022 she received the award and recognition as an international Fellowship of the National Lipid Association (NLA).
Dr Cuevas has published numerous national and international scientific articles, as well as book chapters. She is also an associate editor of leading international scientific journals in her field, including the Journal of Lipid Research, the Current Atherosclerosis Report, and Clinical Obesity.
Since March 2020, she has performed clinical and academic work at the Advanced Center for Metabolic Medicine and Nutrition (CAMMYN) Santiago and Cleversalud Clinic, Rancagua, Chile.
